| Product NDC: | 68084-111 |
| Proprietary Name: | Glipizide |
| Non Proprietary Name: | Glipizide |
| Active Ingredient(s): | 5 mg/1 & nbsp; Glipizide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68084-111 |
| Labeler Name: | American Health Packaging |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076467 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080609 |
| Package NDC: | 68084-111-01 |
| Package Description: | 10 BLISTER PACK in 1 CARTON (68084-111-01) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68084-111-11) |
| NDC Code | 68084-111-01 |
| Proprietary Name | Glipizide |
| Package Description | 10 BLISTER PACK in 1 CARTON (68084-111-01) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68084-111-11) |
| Product NDC | 68084-111 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glipizide |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080609 |
| Marketing Category Name | ANDA |
| Labeler Name | American Health Packaging |
| Substance Name | GLIPIZIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |